Taconic Biosciences is featured in this press release from Pharmatest Services, Ltd., as both have collaborated "to develop a novel humanised mouse model of tumor growth in bone that can be used for testing immunotherapies":
"Testing compound efficacy in bone microenvironment should substantially decrease the very high number of cancer drugs currently failing in clinical trials due to poor efficacy.
Pharmatest Services is a contract research organisation that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. In oncology, Pharmatest has special expertise in models of bone metastasis. Taconic Biosciences focuses on genetically engineered rodent models and services."
Pharmatest Services is a contract research organisation that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. In oncology, Pharmatest has special expertise in models of bone metastasis. Taconic Biosciences focuses on genetically engineered rodent models and services."
Read the complete press release at: Pharmatest.com